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cz,-Antitrypsin &AT) is known to be oxidised by reactive oxygen species both in vitro and in vivo, leading to its inactivation. We report here that 
synovial fluid (SF) u,AT is inactivated uring exercise of the knee-joints of rheumatoid arthritis (RA) patients. Sequential SF sampling from 
exercised RA patients showed a marked decrease in the mean activity of a,AT after exercise with no change in the molecular forms of cc,AT. No 
such inactivation was found in the control (continuously resting) RA patients. We suggest hat oxidation may contribute to a,AT inactivation as 
a consequence of ‘hypoxic-reperfusion’ injury after exercise of the inflamed joint. 
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1. INTRODUCTION 
The inflamed human knee-joint provides an example 
of hypoxic reperfusion injury [l]. This form of injury 
occurs when tissue ischaemia is followed by the restora- 
tion of the blood supply, and involves the generation of 
reactive oxygen species (ROS) [2]. In rheumatoid arthri- 
tis (RA), joint hypoxia is caused, in part, by occlusion 
of the synovial capillary bed during exercise, whilst sub- 
sequent rest results in reperfusion. An hypoxic-reperfu- 
sion event may result in ROS generation due to activa- 
tion of the xanthine-xanthine oxidase system within the 
synovium [3] or stimulation of the NADPH oxidase 
activity of neutrophils sequestered in the inflamed joint 
[4]. ROS-damaged biomolecules, such as IgG [5] and 
lipids [6], have been identified in the knee-joint synovial 
fluid (SF) of RA patients. Increases in the levels of these 
products are detectable following exercise-induced hy- 
poxic reperfusion injury [ 1,7]. 
centre, which is located in a highly stressed exposed 
loop [lo]. ol,AT (54 kDa) inhibits neutrophil elastase by 
rapidly forming a stable one-to-one complex (83 kDa), 
which remains tightly bound until removed from the 
circulation [lo]. However, a,AT can be rendered inac- 
tive in terms of its inhibitory capacity towards elastase 
by two different mechanisms: either oxidation of the 
reactive centre Met358 to methionine sulphoxide by ROS 
[lo], or cleavage of any one of a number of peptide 
bonds close to the reactive centre by proteinases, includ- 
ing matrix metalloproteinases [ 111. 
Human a,-antitrypsin (ct,AT) is a member of the ser- 
pin (se&e proteinase inhibitor) superfamily of proteins 
[8]. It is an acute phase reactant and is used as an index 
of disease activity. a,AT is the natural inhibitor of neu- 
trophil elastase, which may contribute to connective 
tissue destruction in several diseases, such as pulmonary 
emphysema nd RA [9]. The reactive centre of a,AT 
contains a Met358-Ser359 peptide bond at its reactive 
A proportion of ol,AT is present in an inactive form 
in RA SF [12] and in the bronchoalveolar lavage fluid 
of pulmonary emphysema patients [13]. Oxidised [14] 
and cleaved [ 151 forms of a,AT have been found in RA 
SF. We have shown previously that, on average, 41% 
of total a,AT in RA SF is inactive in an ambulatory 
rheumatoid population [16], although there was a large 
variation between the individuals in this population. We 
hypothesised that the presence of oxidised cc,AT and the 
variability of oxidation might both be the consequence 
of exercise-induced oxidative damage. We therefore ex- 
amined the effect of exercise on the inactivation of SF 
cr,AT in the rheumatoid joint, and subsequently deter- 
mined whether the dominant mechanism was proteoly- 
sis or oxidation. 
2. MATERIALS AND METHODS 
Correspondence: P. Winyard, The Inflammation Research Group, Ar- 
thritis and Rheumatism Council Building, London Hospital Medical 
College, 25-29 Ashfield Street, London El 2AD, UK. Fax: (44) (71) 
377-7763. 
Abbreviations: a,AT, a,-antitrypsin; ROS, reactive oxygen species; 
RA, rheumatoid arthritis; SF, synovial fluid. 
2.1. Synovial &id and plasma 
Following local ethical committee approval for the clinical protocol 
ten patients were selected for study. All conformed to the American 
Rheumatism Association criteria for ‘definite RA’, and had active 
disease for 0.5 to 22 years. They were between 35 and 77 years of age. 
Each patient was randomly divided into one of two groups, ‘exercised 
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or ‘continuously rested’. For both groups, patients rested supine for 
a minimum period of 20 min. At the end of this period, at least two 
baseline SF samples were obtained by aspirating at -4, -2 or O,, min. 
Following the final baseline sample the five patients designated for 
‘exercise’ walked as briskly as possible for 10 min. The five patients 
designated for ‘continuous rest’ remained recumbent for a further 10 
min. Samples were then taken from both groups immediately after 
exercise/rest and at defined intervals until the knee was dry (Oplt, 2, 
5 min, and so on). A plasma sample was also obtained from each 
patient immediately prior to the start of the exercise/continuous rest 
protocol. Samples were centrifuged (2,OOOxg) at 4’C for 15 min and 
analyzed within 6 h of collection. 
2.2. Immunochemicaf determination of SF a,AT concentration 
The total amount of a,AT in each SF sample was quantified by 
single dimension immunoelectrophoresis [ 161, The within-batch coeffi- 
cient of variation for this method was 1.8% (n = S), and the between- 
batch coefficient of variation was 5.1% (n = 6). The molar concentra- 
tion of a,AT was calculated (M, = 54 kDa) and this value was used 
to calculate the number of moles of active a,AT per mole of total a,AT 
as described below. 
2.3. Kinetic spectrophotometric measurement of SF a,AT activity 
The activity of porcine pancreatic elastase (Sigma, Dorset) was 
determined according to the method of Beatty et al. [17] and the 
preparation of elastase was found to contain 0.64 moles of active 
elastase per mole of total elastase. For each SF and plasma sample, 
five different volumes of SF, containing known amounts of SF a,AT 
from the immunochemical determination, were used in kinetic meas- 
urements at 405 nm. The initial rate of elastase activity thus obtained 
was plotted b-axis) as a function of the molar ratio of a,AT to active 
elastase (x-axis). By extrapolation of the curve obtained to an intercept 
on the x-axis, the number of moles of a,AT needed to completely 
inhibit one mole of porcine pancreatic elastase was calculated. The 
specitk activity of SF a,AT, defmed as the number moles of active 
a,AT per mole of total arAT, was calculated for each SF sample at 
each exercise/rest time point. The percentage change in specific activity 
from the initial (-4 min) basehne value (see Fig. 1) was then calculated 
(fl specific activity, S). 
2.4. SDS-PAGE and Western blotting 
The molecular forms of SF a,AT in each sample were examined by 
10-208 gradient SDS PAGE followed by Western blotting [15]. This 
technique detects three molecular forms of a,AT in the SF from RA 
patients (Fig. 2): (i) the 54 kDa form of a,AT, which may be either 
native or oxidatively inactivated, (ii) the 50 kDa form, a major frag- 
ment of a,AT proteolysis, and (iii) the 83 kDa form, a complex of 
native a,AT with neutrophil elastase. The cleaved N-terminal frag- 
ment of SF a,AT (4 kDa) could not be detected on the blot, presum- 
ably due to a lack of immunochemical reactivity with the antiserum 
used. The intensities of a,AT bands were quantified by the Seescan 
digital imaging system (Cambridge, UK). 
2.5. Statistical analysis 
Statistical analysis was by Student’s r-test. Results were expressed 
as the mean + 1 SD. A P value of < 0.05 was considered to be statisti- 
cally significant. 
3. RESULTS 
The mean concentration of ol,AT in the ten patients 
studied was significantly higher (P < 0.01) in the plasma 
than in the first of the SF samples collected from each 
patient (3.02 k 0.86 compared to 1.72 f 1.15 mg/ml), in 
agreement with earlier results 1181. In addition, the 
mean specific activity of rz,AT was significantly higher 
(P c 0.05) in the plasma than the SF (0.83 + 0.22 com- 
pared to 0.58 + 0.21 moles of active a,AT per mole of 
total a,AT). Comparing the group of patients (n = 5) 
who exercised with the group of patients (n = 5) who 
rested continuously, there was no significant difference 
between the mean plasma values for either a,AT con- 
centration or specific activity. There was also no signif- 
icant difference between the corresponding mean values 
for the first of the SF samples collected from each pa- 
tient. 
The time-course plots for the changes in specific ac- 
tivity of SF &,AT in the exercised and continuously 
rested patients were paired for ease of presentation (Fig. 
1). In the continuously rested group, the changes were 
no greater than those during the baseline period. The 
mean value for the lowest specific activity of the post- 
rest samples was 0.55 + 0.15 moles of active cz,AT per 
mole of total cc,AT. This value was not significantly 
different from the mean activity of a,AT in the baseline 
SF samples (0.55 k 0.19 moles of active SF a,AT per 
mole of total SF a,AT). In contrast, the exercised group 
showed a significant fall after the exercise programme 
was completed. The mean value for the lowest specific 
activity of SF a,AT occurring in the exercised RA pa- 
tients was significantly lower than the mean of the initial 
baseline values in the same group (0.33 + 0.18 com- 
pared to 0.62 + 0.24 moles of active a,AT per mole of 
total oc,AT; P < 0.05). The mean value for the maxi- 
mum decrease in specific activity of SF &,AT after exer- 
cise was 50.0 + 10.7% (Fig. 1). 
When the molecular form of a,AT in SF during the 
exercise and resting protocol was examined by SDS 
PAGE and Western blotting, there was no significant 
change in any of the three cc,AT bands (see section 2) 
in either the exercised or continuously rested patients 
(Fig. 2). In the patients studied here, the ratio of the 
cleaved rz,AT band intensity to the native cc,AT band 
intensity agreed with previously published data [15]. 
4. DISCUSSION 
The specific activity of SF a,AT was employed as an 
index of protein damage within the inflamed human 
joint, and was used to monitor the effect of hypoxic 
reperfusion injury within the joint as a consequence of 
joint exercise. The results demonstrated that exercise 
promoted SF oz,AT inactivation, whilst patients sam- 
pled sequentially during continuous rest showed no 
such alteration in functional cc,AT. 
It has been demonstrated, in vivo, that the inflamed 
rheumatoid joint has a positive synovial cavity pressure 
that rises further with exercise [19]. This pressure rise 
exceeds the capillary perfusion pressure, and causes a 
temporary occlusion of the superficial capillary bed (hy- 
poxia). With cessation of exercise, the blood supply is 
restored (reperfusion). Hypoxia followed by reperfu- 
sion within the synovium will activate the xanthine de- 
hydrogenase/oxidase system, localised in the synovial 
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Fig. 1. Change in SF a,AT specific activity in ‘exercised’ and ‘continuously rested’ RA patients. The specific activity was determined as described 
in section 2. For each SF sample, the total concentration of a,AT was determined by immunoelectrophoresis. Agarose gel (1%) containing 
anti-human a,AT antiserum (OS%, Sigma, Dorset) was made up in 0.0315 M sodium barbital/S.7 mM diethyl barbituric acid/O.187 M Tris/O.375 
M gIycinel5 mM NaN,, pH 8.6. The gel was run for 4 h at 50 mAf50 cm*. After electrophoresis the plate was squash blotted, washed in phosphate 
saline buffer (PBS) and stained with Coomassie brilliant blue. Four standards of purified a,AT (2550, 100 and 200 ng/,ul; Calbiochem, CA) were 
employed. The negative time-points represent times prior to the start of exercise or continuous rest. The solid triangtes represent exercised patients, 
and the open squares continuously rested patients. Measurements are the means of duplicates (duplicates differed by less than 6%). 
capillary endothelium of both healthy and diseased syn- 
ovium [3]. Activation generates both the superoxide 
anion radical and H,O,. In the presence of catalytic iron 
salts, these ROS will react to generate the hydroxyl 
radical via the Haber-Weiss reaction [20]. ROS genera- 
tion by the synovium during ‘hypoxic reperfusion’ cy- 
cles has been demonstrated by electron spin resonance 
with spin trapping [21]. ROS have the capacity to cause 
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Fig. 2. Typical Western blot showing the molecular fonns of (r,AT in RA SF obtained before and after exercise (patient represented in Fig. lb). 
SF a,AT was run on lo%-20% gradient SDS PAGE, and then Western-blotted to nitrocellulose in 30 mM Na&OJ 10 mM NaHC0,/20% methanol 
@H 9.9) at 400 mA for 2-3 h. The blot was blocked with 5% (w/v) bovine serum albumin in PBS, and a monospecific sheep anti-human a,AT 
antiserum (Unipath, Bedford, UK) was then incubated with the blot. After washing away the unbound first antibody, the blot was reprobed with 
a peroxidase-conjugated rabbit anti-sheep immunoglobulin (Dakopatts, High Wycombe, UK). The a,AT bands were visualised by developing with 
0.05% (w/v) diaminobenzidine tetrahydrochloride and 0.002% (v/v) H20, in PBS. Lane 1, -4 min; lane 2, Opre min; lane 3, Or,,, min; lane 4, 2 min; 
lane 5, 5 min; lane 6; 8 min; lane 7, purified a,AT (native form). 
direct oxidative damage to biomolecules, including 
a,AT. Active &,AT has a methionine residue at its reac- 
tive centre, which can be readily oxidised to methionine 
sulphoxide by ROS [8,10]. When the methionine at the 
reactive centre is oxidized, the activity of ol,AT against 
elastase is diminished. 
The inactivation of SF a,AT after exercise was tran- 
sient. This might be due to the rapid ingress and egress 
of a,AT across the synovial membrane during exercise, 
since both the concentration and specific activity of 
a,AT in plasma was significantly higher than in SF. 
Although the passage of plasma proteins across the 
synovial membrane is a slow process in normal situa- 
tions, the joint physiology may be different immediately 
after exercise of the inflamed joint, perhaps as a conse- 
quence of a reactive hyperaemia. It is noteworthy that 
the concentrations of both total SF a,AT and total 
protein varied substantially in samples derived from the 
repeated aspiration of SF after exercise (data not 
shown). The fluctuations were greater than the ‘noise’ 
of the assay itself, but there was no obvious pattern in 
the changes. This suggests that bidirectional protein ex- 
change between SF and synovium may have occurred 
following exercise, with the net effect of the observed 
fluctuating increases and decreases of ol,AT concentra- 
tion. However, movement of &,AT between the blood 
and SF compartments could not account for the ob- 
served decrease in a,AT specific activity because in RA 
the specific activity of plasma a,AT was higher than 
that of SF a,AT. Another possibility is that a,AT may 
be reactivated by methionine sulphoxide-peptide r duc- 
tase. This enzyme has been detected in human lung 
homogenate and in human peripheral blood neutrophils 
[ 131, but, to our knowledge, there are no reported stud- 
ies of its activity within the joint. 
In this study, no further proteolysis or cx,AT-neutro- 
phi1 elastase complex formation was detected over the 
time-period studied. In vitro, ROS have been shown to 
activate latent metalloproteinases, uch as human neu- 
trophil collagenase [22]. Since a number of metallopro- 
teinases are capable of degrading a,AT [11,22], ROS 
may indirectly promote the proteolytic inactivation of 
cx,AT and cartilage destruction. a,AT proteolysis due to 
ROS-mediated metalloproteinase activation may occur 
over a longer time-course than that studied here. Cer- 
tainly, a,AT proteolysis does occur, since a cleaved 
form of a,AT has been detected in RA plasma and SF 
(see Fig. 2), being present as a significantly higher pro- 
portion of total a,AT in RA SF [15]. We infer then that 
short-term damage to a,AT in the exercised inflamed 
human joints was not due to proteolysis, and therefore 
oxidative damage is implicated. 
In conclusion, our study demonstrates that SF &,AT 
is inactivated by exercise of the inflamed rheumatoid 
joint, which we believe is attributable to the production 
of ROS. Many previously reported studies have at- 
tempted to relate disease activity to biochemical para- 
meters in SF. It is clear that brief exercise might consid- 
erably influence such measurements and we know of no 
studies where this effect has been considered. 
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